PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4
Open accessPublished version of a preprint
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Luteolin is a flavonoid found in high concentrations in celery and green pepper, and acts as a neuroprotectant. PSMC5 (proteasome 26S subunit, ATPase 5) protein levels were reduced after luteolin stimulation in activated microglia. We aimed to determine whether regulating PSMC5 expression could inhibit neuroinflammation, and investigate the underlying mechanisms.BV2 microglia were transfected with siRNA PSMC5 before the addition of LPS (lipopolysaccharide, 1.0 µg/ml) for 24 h in serum free DMEM. A mouse model of LPS-induced cognitive and motor impairment was established to evaluate the neuroprotective effects of shRNA PSMC5. Intracerebroventricular administration of shRNA PSMC5 was commenced 7 days prior to i.p. injection of LPS (750 μg/kg). Treatments and behavioral experiments were performed once daily for 7 consecutive days. Behavioral tests and pathological/biochemical assays were performed to evaluate LPS-induced hippocampal damage. Molecular dynamics simulation was used to confirm the interaction between PSMC5 and TLR4 (Toll-like receptor 4) in LPS-stimulated BV2 microglia. SiRNA PSMC5 inhibited BV2 microglial activation, and suppressed the release of inflammatory factors (IL-1β, COX-2, PGE 2 , TNF-α, and iNOS) upon after LPS stimulation in BV2 microglia. LPS increased IκB-α and p65 phosphorylation, which was attenuated by siRNA PSMC5. Behavioral tests and pathological/biochemical assays showed that shRNA PSMC5 attenuated LPS-induced cognitive and motor impairments, and restored synaptic ultrastructure and protein levels in mice. ShRNA PSMC5 reduced pro-inflammatory cytokine (TNF-α, IL-1β, PGE 2 , and NO) levels in the serum and brain, and relevant protein factors (iNOS and COX-2) in the brain. Furthermore, shRNA PSMC5 upregulated the anti-inflammatory mediators interleukin IL-4 and IL-10 in the serum and brain, and promoted a pro-inflammation-to-anti-inflammation phenotype shift in microglial polarization. Mechanistically, shRNA PSMC5 significantly alleviated LPS-induced TLR4 expression. The polarization of LPS-induced microglial pro-inflammation phenotype was abolished by TLR4 inhibitor and in the TLR-4 −/− mouse, as in shRNA PSMC5 treatment. PSMC5 interacted with TLR4 via the amino sites Glu284, Met139, Leu127, and Phe283. PSMC5 site mutations attenuated neuroinflammation and reduced pro-inflammatory factors by reducing TLR4-related effects, thereby reducing TLR4-mediated MyD88 (myeloid differentiation factor 88)-dependent activation of NF-κB. PSMC5 could be an important therapeutic target for treatment of neurodegenerative diseases involving neuroinflammation-associated cognitive deficits and motor impairments induced by microglial activation. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In fact, PSMC5 was identified as a potential therapeutic target for the treatment of neurodegenerative diseases involving neuroinflammation-associated cognitive deficits and motor impairments induced by microglial activation [11].”
From Strengthening the Role of PSMC5 as a Potential Gene Associated with Neurodevelopmental Disorders (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“As documented, the intracerebroventricular administration of shRNA PSMC5 in mice resulted in neuroprotective effects.”
From Strengthening the Role of PSMC5 as a Potential Gene Associated with Neurodevelopmental Disorders (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Santos, A. G., da Rocha, G. O., & de Andrade, J. B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37186-2 · Cited by 8,495
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · cited 1×
“TLR4 can recognize conserved motifs in various pathogens and mediate defense responses [47].”
BackgroundA human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590 · cited 1×
“Triggering the TLR4 pathway often leads to activation of NF-κB and subsequent regulation of immune and inflammatory genes [48].”
BackgroundDifferential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · cited 2×
“…of microglia phenotypes from the pro-inflammatory, cytotoxic M1 to anti-inflammatory, neuroprotective M2 could be a therapeutic approach for some neurodegenerative diseases associated with neuroinflammation such as Alzheimer’s and Parkinson’s diseases, and amyotrophic lateral sclerosis [9].”
BackgroundPHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526 · cited 1×
“…(i.c.v.) shRNA PSMC5 (lentiviruses encoding mouse shRNA PSMC5; constructed and produced by Obio Technology, Shanghai; 1 × 10 8 TU/mL) administration was performed using a microsyringe with the stereotaxic coordinates − 0.26 cm dorsal, − 0.15 cm lateral, and − 0.02 cm anterior from bregma [19].”
MethodInfluentialMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Localization of IBA1 (ionized calcium-binding adapter protein 1) protein is restricted to microglia in vitro and in vivo, and IBA1 protein plays a role in regulating microglial function, especially in activated microglia [46].”
BackgroundSignal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254 · cited 1×
“LPS, a specific ligand for TLR4, primarily activates the MyD88-dependent and independent pathways, which involve recognition of the lipid A-region of LPS by TLR4 [5].”
BackgroundOshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,207
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · cited 1×
“Activated microglia secrete a variety of proinflammatory and neurotoxic factors that can directly affect cognition and memory [2, 3].”
BackgroundKim, Y.-J., Björklund, S., Li, Y., Sayre, M. H., & Kornberg, R. D. (1994) · Cell · doi:10.1016/0092-8674(94)90221-6 · Cited by 1,090 · cited 1×
“PSMC5 was subsequently identified as a component of a multiprotein mediator of transcription factor-dependent transcription by RNA polymerase II (pol II) holoenzyme from S. cerevisiae [30].”
Background
Cited by
Tian, Y., Jing, G., Ma, M., Yin, R., & Zhang, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105848 · Cited by 42
Cao, T., Li, A.-Q., Zhang, Y., Xie, T.-T., Weng, D.-Z., Pan, C., Li, Y., Sun, K., Wang, D., Han, J.-Y., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156432 · Cited by 39
Convergence of sepsis-associated encephalopathy pathogenesis onto microglia
Xiao, D., Wang, X., Liang, W., Yang, Y., Du, Y., Liu, C., Xu, F., Yang, Y., Wei, M., & Yang, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06635-8 · Cited by 35
Wei, J., Chen, A., Huang, D., Teng, C., Cai, D., Wu, X., Wang, T., Hu, W., Huang, Z., Wang, P., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.029 · Cited by 27
Liu, T., Zhang, L., & Mei, W. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09933-x · Cited by 16
Metadata
- Authors
- Bi, W., Bao, K., Zhou, X., Deng, Y., Li, X., Zhang, J., Lan, X., Zhao, J., Lu, D., Xu, Y., Cen, Y., Cao, R., Xu, M., Zhong, W., & Zhu, L.
- Affiliations
- University of Jinan (CN)
- Jinan University (CN)
- Corresponding author
- Zhu, Lihong
- ORCID
- Venue
- Journal of Neuroinflammation
- Published
- 2023-11-24
- Volume
- 20
- Issue
- 1
- Pages
- 277-277
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC10668523
- OpenAlex
- W4388971273
- Cited by
- 36
- References
- 54
- Citations by year
- 2026: 5 · 2025: 19 · 2024: 12
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Guangdong Basic and Applied Basic Research Foundation (Nos.2022A1515010842)
- the Science and Technology Program of Guangzhou (Nos.202102010099, Nos. SL2023A03J00699)
- the Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University (Nos. JNU1AF-CFTP-2022-a01216)
- the Natural Science Foundation of China (Nos.82071568)
- the Administration of Traditional Chinese Medicine of Guangdong Province (Nos.20202041)
- the Guangzhou Key Laboratory for Germ-free animals and Microbiota Application ((Nos.202201020381))
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- microglial polarization, microglial activation, TLR4, lipopolysaccharide, neuroinflammation, cognitive impairment, motor impairment, hippocampal lesions, neuroprotection, luteolin, NF-κB signaling, inflammatory cytokines, synaptic ultrastructure, anti-inflammatory cytokines
- MeSH terms
- Motor Disorders, ATPases Associated with Diverse Cellular Activities, Neuroinflammatory Diseases, Animals, Cognition, Inflammation, Lipopolysaccharides, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Microglia, RNA, Small Interfering, Proteasome Endopeptidase Complex, Luteolin, Toll-Like Receptor 4, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4. https://app.cochat.ai/papers/10.1186/s12974-023-02904-9
- The paper
- Bi, W., Bao, K., Zhou, X., Deng, Y., Li, X., Zhang, J., Lan, X., Zhao, J., Lu, D., Xu, Y., Cen, Y., Cao, R., Xu, M., Zhong, W., & Zhu, L. (2023). PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-023-02904-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.